Optiscan Imaging Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 8

Employees

  • Stock Symbol
  • OIL

Stock Symbol

  • Share Price
  • $0.08
  • (As of Thursday Closing)

Optiscan Imaging General Information

Description

Optiscan Imaging Ltd is engaged in the development, manufacture and commercialisation of proprietary confocal imaging devices and digital solutions for surgical, pathology and veterinary applications. Activities included the advancement of the company's InVueTM, InFormTM and InSpectaTM platforms through product development, clinical studies, regulatory activities, strategic collaborations and commercialisation initiatives. The group operated predominantly in the confocal microscope industry. It has presence in Germany, China, Australia, and United States. Majority of revenue comes from Germany. Its products are Optiscan InVueTM, Optiscan InFormTM, Optiscan InVivage, Optiscan ViewnVivo, and Optiscan InSpectaTM.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 16 Miles Street
  • Mulgrave, Victoria 3170
  • Australia
+61 (03)
Primary Industry
Diagnostic Equipment
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • 16 Miles Street
  • Mulgrave, Victoria 3170
  • Australia
+61 (03)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optiscan Imaging Stock Performance

As of 19-Nov-2026, Optiscan Imaging’s stock price is $0.08. Its current market cap is $87.7M with 1.05B shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.08 $0.09 $0.06 - $0.14 $87.7M 1.05B 182K

Optiscan Imaging Financials Summary

As of 30-Sep-2026, Optiscan Imaging has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 89,558 75,074 55,316 121,772
Revenue 304 616 757
EBITDA (4,820) (3,993) (3,943)
Net Income (4,733) (4,084) (3,972)
Total Assets 15,161 6,895 10,447
Total Debt 925 967 148
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Optiscan Imaging Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Optiscan Imaging‘s full profile, request access.

Request a free trial

Optiscan Imaging Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Optiscan Imaging Ltd is engaged in the development, manufacture and commercialisation of proprietary confocal imaging de
Diagnostic Equipment
Mulgrave, Australia
8 As of 2015

Marlborough, MA
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Optiscan Imaging Competitors (5)

One of Optiscan Imaging’s 5 competitors is Hologic, a Private Equity-Backed company based in Marlborough, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hologic Private Equity-Backed Marlborough, MA
Mauna Kea Technologies Formerly VC-backed Paris, France
iCAD Corporate Backed or Acquired Nashua, NH
UE LifeSciences Venture Capital-Backed Philadelphia, PA
Elliquence Corporate Backed or Acquired Baldwin, NY
You’re viewing 5 of 5 competitors. Get the full list »

Optiscan Imaging Patents

Optiscan Imaging Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020902979-A0 Optical probe and processing system Pending 21-Aug-2020
WO-2022036400-A1 Optical probe and processing system Inactive 21-Aug-2020
US-11559189-B2 Sterile sheath for confocal endomicroscopy scanner probe Active 31-Oct-2018
US-20200129049-A1 Sterile sheath for confocal endomicroscopy scanner probe Active 31-Oct-2018
JP-2016524188-A Optical scanner and scan lens optical probe Active 19-Jun-2013 A61B1/043
To view Optiscan Imaging’s complete patent history, request access »

Optiscan Imaging Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optiscan Imaging Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Optiscan Imaging‘s full profile, request access.

Request a free trial

Optiscan Imaging ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Optiscan Imaging’s complete esg history, request access »

Optiscan Imaging FAQs

  • When was Optiscan Imaging founded?

    Optiscan Imaging was founded in 1994.

  • Where is Optiscan Imaging headquartered?

    Optiscan Imaging is headquartered in Mulgrave, Australia.

  • What is the size of Optiscan Imaging?

    Optiscan Imaging has 8 total employees.

  • What industry is Optiscan Imaging in?

    Optiscan Imaging’s primary industry is Diagnostic Equipment.

  • Is Optiscan Imaging a private or public company?

    Optiscan Imaging is a Public company.

  • What is Optiscan Imaging’s stock symbol?

    The ticker symbol for Optiscan Imaging is OIL.

  • What is the current stock price of Optiscan Imaging?

    As of 19-Nov-2026 the stock price of Optiscan Imaging is $0.08.

  • What is the current market cap of Optiscan Imaging?

    The current market capitalization of Optiscan Imaging is $87.7M.

  • Who are Optiscan Imaging’s competitors?

    Hologic, Mauna Kea Technologies, iCAD, UE LifeSciences, and Elliquence are competitors of Optiscan Imaging.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process